CLUISTROM LIMITED
Opportunity 77/100 (strong), bankability 85/100. Strong seller-intent signal (68/100, director aged 57). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Refinance opportunity
2 live charges · oldest 8.8y
Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.
- · Oldest live charge is 8.8 years old — likely at or near maturity.
- · Single lender — cleanest path to refinance.
- · Distress signals active — lender appetite narrows.
Data confidence
Overall: high (81/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Average employees | 5 | 400 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 2 mortgage
- • 1 accounts
Corporate timeline (22 events)Click to expand
- 2025-12-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-10-27📄mortgage-satisfy-charge-fullmortgage · MR04
- 2025-10-27📄mortgage-satisfy-charge-fullmortgage · MR04
- 2025-10-27🔓Charge satisfied #2
- 2025-10-27🔓Charge satisfied #1
- 2025-10-17📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2025-10-16📄change-person-director-company-with-change-dateofficers · CH01
- 2025-10-16📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2024-12-04📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-13📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-08-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-06-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-09-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-12-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-08-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-07-15📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2017-07-15📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2017-07-12🔒Charge registered #2Lender: Starkey Laboratories Limited
- 2017-07-12🔒Charge registered #1Lender: Starkey Laboratories Limited
- 2011-01-07🏢Company incorporatedAs CLUISTROM LIMITED
- 2011-01-07➕MCINTOSH, John Neil appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 15 years — deep operational knowledge concentrated in one person.
- +No director turnover: Company is 15 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 15 years.
- secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr John Neil Mcintosh Individual · British · DOB 03/1969 · age 57 | 75–100% | 75–100% | board controlsig. influence75-100% shares · 75-100% voting · board control · significant influence · trust interest · firm interest | 14/10/2025 |
1 historic (ceased) PSC
- Starkey Hearing Labrotoriesceased 14/10/2025· 25-50% shares
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · KY postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| BAKOLINA LIMITED→ SC811315 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| BALBIRNIE ORAL CARE LIMITED→ SC430660 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| CHARLESTOWN PHARMACY LIMITED→ SC391110 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| COMELY PARK DENTAL PRACTICE LTD.→ SC445337 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| CONNECTED CARE SERVICES LTD→ SC633734 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| CORNUCOPIA 8 LTD→ SC837499 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| D ALLAN LIMITED→ SC244241 · est 2003 · no financials extracted | — | — | — | — | 23y | — | — |
| DAUGHTERS OF ZELOPHEHAD LTD→ SC653216 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| DC DENTAL LIMITED→ SC869245 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DENHOLM HAY LIMITED→ SC414900 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| DR CAMPBELL PSYCHOTHERAPY LTD→ SC848333 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DR DAVID STEPHENS LIMITED→ SC474609 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| satisfied | Starkey Laboratories Starkey Laboratories Limited | A registered charge | — | 12/07/2017 | 27/10/2025 | |
| satisfied | Starkey Laboratories Starkey Laboratories Limited | A registered charge | — | 12/07/2017 | 27/10/2025 |